Quick Answer
NeuroPace Inc reported Stockholders Equity of $19.03 million for the year ending 2025.
- NeuroPace Inc showed an increase of +137.5% in Stockholders Equity from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$135.83 million | Q2 2020: -$144.29 million | Q3 2020: -$143.74 million | Q1 2021: -$156.44 million | Q2 2021: $88.67 million | Q3 2021: $81.71 million | Q1 2022: $62.82 million | Q2 2022: $52.90 million | Q3 2022: $43.41 million | Q1 2023: $27.49 million | Q2 2023: $21.23 million | Q3 2023: $16.36 million | Q1 2024: $14.34 million | Q2 2024: $9.89 million | Q3 2024: $9.82 million | Q1 2025: $24.27 million | Q2 2025: $19.44 million | Q3 2025: $18.52 million.
- Over the full 7 years of available data (2019 to 2025), NeuroPace Inc's Stockholders Equity has grown by 114.7%.
- Historical annual values: Fiscal year 2025: $19.03 million | Fiscal year 2024: $8.01 million | Fiscal year 2023: $20.65 million | Fiscal year 2022: $34.78 million | Fiscal year 2021: $73.50 million | Fiscal year 2020: -$147.83 million | Fiscal year 2019: -$129.35 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: